Depletion of ANXA3 in oxaliplatin resistant HCT116 and SW480 colorectal cancer cells inhibits the cell viability and BrdU incorporation, increases apoptosis and diminishes migration and invasion. This evidence concerns the gene ANXA3 and colorectal cancer.